Bacampicillin
From Wikipedia, the free encyclopedia
 |
|
|
Bacampicillin
|
|
| Systematic (IUPAC) name | |
| 1-Ethoxycarbonyloxyethyl (2S,5R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate | |
| Identifiers | |
| CAS number | |
| ATC code | J01 |
| PubChem | |
| Chemical data | |
| Formula | C21H27N3O7S |
| Mol. mass | 465.519 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Rapidly hydrolyzed to ampicillin |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
Bacampicillin (INN) is a penicillin antibiotic. It is a prodrug of ampicillin with improved oral bioavailability.[1]
It is sold under the brand names Spectrobid (Pfizer) and Penglobe (AstraZeneca).
[edit] References
- ^ Bodin NO, Ekström B, Forsgren U, et al (November 1975). "Bacampicillin: a new orally well-absorbed derivative of ampicillin". Antimicrob Agents Chemother 8 (5): 518–25. PMID 1211909.
 |
This antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||
